🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT05104658
Active, not recruiting Not applicable

Heart Rehabilitation for All

NCT05104658 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2022-04-01
Last updated
2024-08-26

Condition(s) studied

Ischemic Heart DiseaseCardiac Valve SurgeryPersistent Atrial FibrillationHeart Failure

Investigational drug(s) / intervention(s)

Patient-targeted rehabilitation offers

Patient-targeted rehabilitation offers: In addition to usual rehabilitation services, patients in the intervention arm will receive patient-targeted rehabilitation offers to support the patients' participation and completion of their heart rehabilitation course.

Study summary

Today, 50 % of cardiac patients do not participate in cardiac rehabilitation due difficulties in navigating and accessing rehabilitation activities.

HeRTA is a partnership project involving Center for Clinical Research and Prevention (CCRP), Hvidovre Hospital, Rehabilitation Center Albertslund and Copenhagen (municipalities), the Danish Heart Association, and local sports associations. A patient advisory board participate throughout the project to ensure a continued focus on patient interests.

The overall aim of HeRTA is to develop and test the feasibility of a new, sustainable model for rehabilitation supporting patients to take part in rehabilitation and promoting life-long activity for all patients with heart disease. To ensure equal access to rehabilitation some activities are open to all patients, while others are tailored specifically to patients with vulnerability.

The project unfolds in three phases: Development (1. January 1. 2020 - 14. November 2021): Partners and patients co-create content and procedures; Feasibility (15. November 2021 - 31. July 2023): The feasibility of the model is tested, and promising components are identified; Long-term follow-up and implementation (1. August 2023 - 31. December 2025): Long term effects are investigated and promising components are tested in new settings.

During the feasibility phase the investigators will examine whether the intervention activities are feasible, acceptable, and may have positive effects for patients with heart disease. The investigators use qualitative data on implementation and acceptability of intervention among partners and patients. An randomisered controlled trial (RCT) component will assess effects on patient participation rates, health, physical activity level, and life quality. Data is collected from practitioners and patients through focus groups, observations, field notes, questionnaires, and interviews.

Results will point to:

* innovative ways to organize integrated rehabilitation pathways.
* approaches to ensuring rehabilitation targeted at patient needs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Diagnosed with ischaemic heart disease, cardiac valve surgery, persistent atrial fibrillation, or heart failure 2. Resident in Hvidovre Hospitals uptake area 3. Cognitively functional 4. Physically able to participate in rehabilitation activities Exclusion Criteria: * Patients, who do not meet the inclusion criteria.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Center for Clinical Research and Prevention Frederiksberg Copenhagen

More Center for Clinical Research and Prevention trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05104658 on ClinicalTrials.gov ↗ ← All trials in Denmark